“…Concomitantly, enhanced anti-9-O-AcSGP-specific antibody responses against these parasite-specific sialoglycoproteins have been witnessed as a part of the host defense mechanism (5,6,10,39). Furthermore, these antibodies, as reported earlier, are leishmanicidal in activity; that is, they are capable of triggering the classical complement pathway, thereby causing Leishmania cell death (5). Alternatively, several other 9-OAcSGPs have been documented on immune cells (65, 56, and 19 kDa) and erythrocytes (112, 107, 103, 57, 51, and 48 kDa) of VL patients (4,11,22).…”